This study focused on understanding the coping strategies and related behavioural changes of women who were recently diagnosed with herpes simplex virus type 2. In particular, we were interested in how coping strategies, condom use, and acyclovir uptake evolve over time. Twenty-eight women screening positive for herpes simplex virus type 2 were recruited through a public health STD clinic and the Indianapolis Community Court. Participants completed three semi-structured interviews with a woman researcher over a six-month period. The interviews focused on coping strategies for dealing with a diagnosis, frequency of condom use, suppressive and episodic acyclovir use, and the utilisation of herpes simplex virus type 2 support groups. Interview data were analysed using content analysis to identify and interpret concepts and themes that emerged from the interviews. Women employed a variety of coping strategies following an herpes simplex virus type 2 diagnosis. Of the women, 32% reported an increase in religious activities, 20% of women reported an increase in substance use, and 56% of women reported engaging in other coping activities. A total of 80% of women reported abstaining from sex immediately following the diagnosis, but 76% of women reported engaging in sex again by the six-month interview. Condom and medication use did not increase and herpes simplex virus type 2 support groups were not utilised by participants. All participants reported engaging in at least one coping mechanism after receiving their diagnosis. A positive diagnosis did not seem to result in increased use of condoms for the majority of participants and the use of acyclovir was low overall.
Introduction
Herpes simplex virus type 2 (HSV-2) is an extremely common sexually transmitted infection (STI). The age-adjusted seroprevalence rate in the United States is 17.0%, with women having a seroprevalence rate almost double that of men (men 11.2% and women 23.1%). 1 The majority of people infected with HSV-2 experience no symptoms and thus may be unaware of their infection, despite shedding virus and potentially transmitting HSV-2 unintentionally to their sexual partners. 2 Diagnosis and treatment of HSV-2 infection is important given its association with increased susceptibility to other STIs, including HIV. [3] [4] [5] By expanding access to HSV-2 serological testing, community-level prevalence could be reduced, as asymptomatic individuals who know their serostatus may take measures to decrease the probability of transmission to uninfected partners through suppressive therapy, condom use, and avoiding sexual contact during outbreaks. 6 Previous research indicates that condom use can reduce the transmission of HSV-2. 7, 8 However, the extent to which a person changes their condom use behaviours after learning of their HSV-2 diagnosis is less known. The use of daily suppressive acyclovir also reduces asymptomatic viral shedding and transmission. [9] [10] [11] Acyclovir could be a useful tool in reducing HSV-2 transmission, but due to the difficulty in taking the medication regularly, it is not clear which women would be willing to use it.
A diagnosis of HSV-2 can be psychologically distressing; particularly for persons who have never experienced symptoms and are unaware they are seropositive. 12, 13 However, severe, lasting negative emotional effects generally have not been found to be associated with an HSV-2 diagnosis. [14] [15] [16] [17] Understanding women's coping strategies after receiving an HSV-2 diagnosis is necessary for the development of evidence-based resources for HSV-2-positive individuals. For example, HSV-2 support groups have been established in many areas in the US and may serve as a useful coping mechanism for individuals recently diagnosed with HSV-2.
The purpose of this study was to better understand the coping strategies and related behavioural changes of women who were recently diagnosed with HSV-2. We were interested in how coping strategies, condom use, and acyclovir uptake evolve over time. Findings from this study will provide increased understanding about coping mechanisms used by HSV-2-positive patients and may be informative for clinicians providing care to these patients.
Materials and methods

Settings
From October 2009 to June 2010, women screening positive for HSV-2 were recruited through two different venues: an STD clinic (Bell Flower Clinic) and the Indianapolis Community Court. Two of the most common charges among women at community court include prostitution and public intoxication. Because of the STI-risk associated with commercial sex and substance abuse, particular outreach efforts have been made to increase access to STI care for this population. 18 A few women had previously experienced HSV-2 symptoms, such as blisters or itching, but the majority of women were asymptomatic prior to testing. Some women developed HSV-2 symptoms post-diagnosis.
Recruitment
Individuals attending the STD clinic were offered an HSV-2 serology test for a $30 fee. 19 Women defendants from the community court were offered no-cost HSV-2 serologic testing. 20 A total of 14 women were enrolled from the STD clinic and 14 were enrolled from community court. Participants recruited from both locations were given 90-day prescriptions for acyclovir and referred to their primary care physician for follow-up.
Procedures
Participants at both locations were women, 18 years of age or older and spoke English fluently. They completed three hour-long, face-to-face, semi-structured interviews with a woman researcher. The first interview was conducted within two weeks of receiving an HSV-2 diagnosis. The second interview occurred 4-7 weeks later, and the final interview occurred approximately six months after diagnosis. The interviews explored how receiving a HSV-2 diagnosis affected participants' mental health and health behaviours over time. Items were grouped into four key domains, including: coping strategies for dealing with a diagnosis, frequency of condom use, suppressive and episodic acyclovir use, and the utilisation of HSV-2 support groups. Table 1 provides a list of key domains and related exemplar items to elicit participant response. During the interviews, participants were provided basic educational information about HSV-2, including how HSV-2 is transmitted, the use of condoms and daily suppressive 
Analysis
We focused on changes in women's attitudes and behaviours over time; because interviews were individually tailored, not every participant was asked about their experience with each domain at all three time points. To conduct our analyses, we organised the transcripts in chronological order by participant and read the transcripts of each participant one-by-one, which allowed us to focus on factors related to change at the individual-level. This strategy is recommended by Saldan˜a for analysing qualitative data for change over time. 21 We included data from women for whom there was a response to key items in two or more of the interviews for each domain. Of the 28 enrolled, three were excluded because they completed only one interview. Data from this study were analysed using content analysis to identify and interpret concepts and themes that emerged from the interviews. 22 This method involved multiple readings of transcripts and analytical induction via open and axial coding of data using NVivo software (version 10, Doncaster, Australia) to thematically organise transcripts. To describe the sample, descriptive analyses were conducted. To assess behavioural change over time for sexual behaviour, condom use, and acyclovir use, repeated measures ANOVA was used. All quantitative analyses were conducted using SPSS statistical software (version 21, Durham, NC, USA).
Results Participants
In total, 25 women completed more than one interview and were included in the analyses (15 black, nine white, one American Indian). Participant ages ranged from 21 to 61 years (median, 38 years; IQR ¼ 33-47 years) (see Table 2 ). Most participants reported engaging in sexual behaviours with male partners only (88%; n ¼ 22). Of the 13 women recruited from community court, five reported previous involvement in exchanging sex for money or living needs. There were no statistically significant differences in recruitment group composition by race or age. However, women recruited from the community court were significantly more likely to be unemployed (p ¼ .03), have lower educational attainment (p ¼ .03), and report exchanging sex for money or living needs (p ¼ .02).
Coping strategies for dealing with a HSV-2 diagnosis
Women employed a variety of coping strategies following a HSV-2 diagnosis. Most women expressed initial shock and psychological distress. ('Oh my god, it felt like a nightmare. It was the worst day of my life.') Women were most concerned about how they had contracted HSV-2 and that HSV-2 could not be cured. Women reported engaging in a variety of behaviours to cope with their diagnosis, including an increase in religious activities, reaching out to friends or family for support, and an increase in consumption of alcohol and drugs. Below we explore each coping strategy in detail.
The role of religion and spirituality
For some women (32%, n ¼ 8), their diagnosis caused them to increase the frequency of prayer and religious service attendance. Participants stated that spiritual activities helped them alleviate feelings of guilt ('I went to church and felt relief. I got to clear my conscience for a little while, and I felt like that was important because I needed that.'), better understand what happened ('I just prayed about it for the most part. Sometimes I just try to get an understanding of what happened.') and receive support ('I pray a lot, and if I The role of substance use Nearly 20% of women mentioned an increase in alcohol and drug use following their HSV-2 diagnosis.
Reports of alcohol and drug use were similar between participants recruited from community court (n ¼ 3) and the STD clinic (n ¼ 2). Participants stated the substance use helped them forget about their diagnosis ('I drink, smoke marijuana, try to forget about it.'), or feel better ('Weed, wine, whatever I feel is best at that time. More drugs, more prescriptions, NyQuil, anything to just make me sleep or make me feel better, that's what I do.').
Coping over time
Coping behaviours seemed to be more important for women at the initial interview than at the last interview, which indicates the need for coping mechanisms may decrease as time progresses and women adjust to their diagnosis. Interestingly, although women engaged in a variety of coping mechanisms, none of the participants reported an interest in attending support groups for people diagnosed with HSV-2, even though participants were given extensive information about a local group.
Preventing transmission to partners: Sexual activity
In addition to examining coping methods, we examined women's sexual behaviour, condom use and medication use over time. There was a significant increase in the number of women reporting sexual activity over time (F(1, 20) ¼ 22, p 0.01, Z 2 ¼ .524). The majority of women (80%; n ¼ 20) reported abstaining from sex immediately after their diagnosis. However, as time progressed, most women reinitiated sexual relationships. By the six-month interview, 76% of respondents had engaged in sexual behaviour again. We use narrative data from one participant to illustrate this progression. At the first interview, one woman stated, 'I'm having the trust issue, and I feel like maybe I want to [have sex], but I just can't bring myself to right now. I'm not on that level yet. There's just so many things that I have to iron out before I even go there.' In an interview weeks later, she said, 'We've not been intimate yet.
We're sticking to the dating process. . .sort of like starting over. We do a lot of kissing like we did when we were first dating. It's working out.' Six months later, she reported, 'Yes, we have [had sex]. In the beginning, it was rough. Now, we have become closer. There's more communication.' This process was similar across participants. Thus, in this sample, it does not appear that there were long-term negative effects on the women's sexual lives.
Preventing transmission to partners: Condom use
A few women reported an increase in condom use immediately following their diagnosis, but this change was inconsistent over time (F(1, 18 
Women who reported an increase in condom use stated that their diagnosis had made them more cautious, 'Now I'm very cautious about not spreading it. . . I make that my first priority. I know there are still other diseases like HIV and AIDS. I don't want to die, so it's a must that I use condoms.' However, most women reported no change in condom use. Several were already in long-term monogamous relationships in which they did not use condoms because they suspected their partner had already contracted HSV-2 ('No, we don't use protection. I know we should, but me and him don't use protection 'cause I feel it's already too late.'). Some women stated that their sexual partners did not want to use condoms, even though they knew the woman had HSV-2 ('It's complicated. They know that I have it, but they don't want to use condoms. . . they act like it don't phase them.'). Thus, patient and partner knowledge of seroprevalence status alone was not sufficient to increase condom use. Some participants reported cost to be a barrier and found it a hardship to pay for medication. For example, a participant receiving Medicaid stated, 'I have a three dollar co-pay, and I don't have three dollars, but I got to come up with something. I got to get it filled so I can start feeling better. I am willing to go through the treatment and the things I have to do to have normal living.' Others assumed that medication was only necessary for an outbreak and did not realise they would be shedding virus and potentially transmitting HSV-2 to sexual partners. ('I still have not went to get the medicine because I don't feel that I really have any symptoms.') Reportedly, this erroneous belief was validated by their primary physicians, 'My doctor said just to see, and if I have another break out, she'll put me on it, but I haven't had one.' Several participants also expressed resistance to taking pills two times a day every day, 'I hate taking pills. I don't want to take those pills every day.' Given the lack of financial resources to maintain a lifetime of suppressive therapy, limited physician support and the daily dosage regimen, acyclovir may not be an effective tool in preventing HSV-2 transmission, especially among asymptomatic women of low socio-economic status.
Preventing transmission to partners: Acyclovir use
Discussion
Our study results suggest that an HSV-2 diagnosis results in short-term behavioural changes for many women. This study adds a unique contribution to the literature because of its three-time-point longitudinal qualitative design that enabled an in-depth exploration of participants' behavioural changes, including how women cope with an HSV-2 diagnosis, as well as condom and medication use. Additionally, this study provides some insight into differences between two high-risk groups, those recruited from a clinical setting, and those receiving community-based testing.
Most women expressed initial shock and psychological distress. However, as in other studies, this distress waned over time. 14, 23 A large proportion (32%) of participants increased religious activities. While further research would be needed to explore the role of religiosity post-HSV-2 diagnosis, it is possible that religious organisations could be a mechanism for engaging women in care. Women also reported an increase in the consumption of alcohol and drugs (20%). A majority of women (56%) reported engaging in other types of coping behaviours, such as talking with family and friends, writing poems, listening to music, or working. Despite being given information about a local HSV-2 support group, no participants attended. This study indicates that most women engage in healthy behaviours to cope with their HSV-2 diagnosis, but some women may need additional support to refrain from negative coping mechanisms.
Most participants did not report a change in condom usage following their HSV-2 diagnosis. This study found that HSV-2-positive individuals in longterm partnerships may not feel the need to use condoms. In fact, some men reportedly did not want to use condoms, even when they knew their woman partner was HSV-2 positive. Given the role condoms play in reducing the transmission of HSV-2, further research should be conducted to determine ways to increase condom use among HSV-2-positive individuals and their sexual partners.
Medication use was low. Most participants showed little interest in taking acyclovir and felt it was only necessary for outbreaks. This belief was supported by their primary care physicians. A number of participants expressed difficulty in obtaining acyclovir due to a lack of financial resources. This set of findings indicates a need for additional education and for services that make acyclovir more accessible to high-risk populations. 18, 19 Our findings are limited by the fact that this was a small, exploratory study of women residing in one city in the Midwestern United States. The majority of our sample participants were low-income and their experiences may not be generalisable to women from more privileged backgrounds. Research should be conducted among women recently diagnosed with HSV-2 in a private practice. Additionally, 40% of women were symptomatic. This is much higher than the literature reports (10-25%). 24 Further exploration may be needed to see how symptomatic versus asymptomatic women react and the potential types of resources they may need. Furthermore, we relied on self-reported experiences and behaviours provided by participants. Given the nature of face-to-face interviews, social desirability reporting may have occurred. Women in this study were only followed for six months, so it is unclear how an HSV-2 diagnosis affects women over a longer time period. However, we interviewed women at regular intervals, and even with our small sample size, we were still able to detect trends.
In sum, all participants reported engaging in at least one, if not several, coping mechanisms after receiving their diagnosis, both adaptive and maladaptive. A positive diagnosis did not result in increased condom use for the majority of participants and the use of acyclovir was low overall. For this sample, additional resources would be needed to provide women with acyclovir for long-term suppressive therapy. In addition, there is a need for educational interventions regarding viral shedding, the value of condom use, and strategies to enhance adherence to suppressive medication. No participant was interested in attending an HSV-2 support group. Additional studies to identify alternative support resources for HSV-2 patients would be useful. While it may seem counterintuitive, our findings suggest partnering with church services may be one potential recruitment and service provision venue.
